Latest Stilbenoids Stories
IRVINE, Calif., March 30, 2011 /PRNewswire/ -- ChromaDex (OTC Bulletin Board: CDXC) today announced that Nutraceutical International Corporation (Nasdaq: NUTR), one of the nation's largest manufacturers of nutritional supplements, has launched a product featuring ChromaDex's pTeroPure(TM) Pterostilbene in its SolarayÂ® Guaranteed Potency line of products. Solaray Super Resveratrol with Pterostilbene is a product that combines the proven benefits of resveratrol with the high potency,...
GAINESVILLE, Fla., March 23, 2011 /PRNewswire/ -- Clinical studies of Resveratrol--recognized for its proven role in activating the longevity gene to inhibit age-related diseases--have shown that its antioxidant power provides resistance before and after exposure to hazardous radiation. (Logo: http://photos.prnewswire.com/prnh/20110323/CG69998LOGO) Explosions and fires at four nuclear reactors in Japan have created widespread fears about radiation exposure.
IRVINE, Calif., March 11, 2011 /PRNewswire/ -- ChromaDex Corporation (OTC Bulletin Board: CDXC), announced today that the Company has been awarded the 2010 North American Health Ingredients Most Promising Ingredient of the Year award by the independent research company, Frost & Sullivan, for its proprietary branded ingredient pTeroPure(TM) Pterostilbene. "We are extremely pleased that Frost & Sullivan has recognized the potential of pTeroPure in the marketplace," said Frank Jaksch,...
Researchers from Cleveland Clinic's Lerner Research Institute have discovered that resveratrol â€“ a compound found in red wine â€“ when combined with rapamycin can have a tumor-suppressing effect on breast cancer cells that are resistant to rapamycin alone.
EASTON, Pa., Jan. 31, 2011 /PRNewswire/ -- The Danish Council for Strategic Research has granted $3.4 million for a four year study to investigate resveratrol on the management of metabolic syndrome, osteoporosis and chronic inflammation.
Resveratrol, a compound in grapes, displays antioxidant and other positive properties.
It was Paracelsus, the Renaissance physician (1493-1541 A.D.) who first said "the dose makes the poison."
A study was carried out to examine the extent to which quercetin and trans-resveratrol (RSV) prevented inflammation or insulin resistance in primary cultures of human adipocytes treated with tumor necrosis factor-a (TNF-a)â€”an inflammatory cytokine elevated in the plasma and adipose tissue of obese, diabetic individuals.
Vinomis Laboratories Announces Reseller Program for Vindure 900 Resveratrol Supplement Vinomis Laboratories today announced the nationwide expansion of its reseller program for Vindure 900, the leading Resveratrol-based anti-aging supplement.
IRVINE, Calif., Oct.
- A morbid dread of being buried alive. Also spelled 'taphiphobia'.